Forbes Spotlight on Visikol and CEO Dr. Michael Johnson
Mike Johnson2019-02-21T01:30:52-05:00Visikol CEO and Co-Founder Dr. Michael Johnson was named to the Forbes 30 Under 30 list in 2017 and was [...]
Visikol Machine Learning Digital Pathology Services for Drug Discovery
Mike Johnson2019-02-21T02:48:40-05:00WHITEHOUSE STATION, N.J. (PRWEB) OCTOBER 15, 2018 Since the inception of the microscope, researchers and clinicians have characterized tissues through [...]
Thermo Fisher Scientific Webinar Highlighting Visikol’s 3D Cell Culture Assays On Demand for Download
Mike Johnson2019-02-21T01:30:52-05:00If you missed Thermo Fisher Scientific's webinar on LabRoots that focused on Visikol and Visikol's 3D cell culture assays you [...]
Blog Post: In Vitro Mimicry of the Blood Brain Barrier
Mike Johnson2019-02-21T01:30:53-05:00A common question for pharmaceutical companies developing therapeutics for neuroscience applications is the passage of small and large molecules across [...]
Where Do Organs and Bodies on a Chip Fit Into Drug Discovery?
Mike Johnson2019-02-21T01:30:53-05:00In the last decade there has been significant research interest in developing improved in vitro models that reduce the need [...]
Visikol Presentation at SBI2 – New Approaches in Image Processing
Mike Johnson2019-02-21T03:12:23-05:00Application of 3D Cell Culture Models to Evaluating Cancer Drug Efficacy for Precision Medicine The Society of Biomolecular Imaging and [...]